Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Grail
ISIN US3847471014
|WKN A40F8M
Market cap (in EUR)
3,127 m
Country
United States
Sector
Healthcare
Advertisement
Capital at risk. Execution-only service.
Overview
Description
GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 3,127 m |
| EPS, EUR | -10.51 |
| P/B ratio | 1.5 |
| P/E ratio | - |
| Dividend yield | - |
Income statement (2024)
| Revenue, EUR | 116 m |
| Net income, EUR | -1,874 m |
| Profit margin | -1,613.92% |
What ETF is Grail in?
There are 25 ETFs which contain Grail. All of these ETFs are listed in the table below. The ETF with the largest weighting of Grail is the L&G Healthcare Technology & Innovation UCITS ETF USD Acc.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.